Recessive is a quality found in the relationship between two versions of a gene. Individuals receive one version of a gene, called an allele, from each parent. If the alleles are different, the dominant allele will be expressed, while the effect of the other allele, called recessive, is masked. In the case of a recessive genetic disorder, an individual must inherit two copies of the mutated allele in order for the disease to be present.
To play the media you will need to either update your browser to a recent version or update your Flash plugin
Recessive refers to a type of allele which will not be manifested in an individual unless both of the individual's copies of that gene have that particular genotype. It's usually referred to in conjunction with a Punnett square, other types of Mendelian genetics, and frequently contrasted with a dominant pattern of inheritance wherein if one has one copy of the gene, regardless of what the other copy is, that dominant allele will show itself. In the case of a recessive allele, the individual will show the trait which corresponds to that genotype only if both alleles are the same and have that particular recessive characteristic. Now, that recessive characteristic can be one of no functional consequence. This results in differences between individuals such as in eye color or hair color, but it can also refer to a disease. For instance, in cystic fibrosis, which is a very common Mendelian disorder, that disease exists only when there's a malfunction of both genes that correspond to cystic fibrosis. If there is only one mutation, then that recessive mutation can be compensated for by the normal allele. However, when the function of both are lost, then the disease manifests itself as a recessive disease where there is a loss of function and therefore observable disease.
Name: Christopher P. Austin, M.D.
Occupation: Director, NIH Chemical Genomics Center (NCGC); Senior Advisor for Translational Research, Office of the Director
Biography: Dr. Austin's research focuses on development of reagents and technologies to translate genome sequence into functional insights. As director of the NIH Chemical Genomics Center (NCGC), part of a network of screening centers that produce chemical probes for use in biological research and drug development, Dr. Austin is spearheading a chemical genomics program that brings the power of small-molecule chemistry and informatics to the elucidation of gene function. Just as the Human Genome Project accelerated gene identification, this initiative promises to speed discoveries on gene function and lead to the development of new therapies for human disease.